Giulia Romano
Virginia Commonwealth University · 91 works · 5,836 citations · h-index 37
Top works
- RETRACTED: miR-221&222 Regulate TRAIL Resistance and Enhance Tumorigenicity through PTEN and TIMP3 Downregulation
- MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer
- MicroRNA and cancer – A brief overview
- RETRACTED ARTICLE: EGFR and MET receptor tyrosine kinase–altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers
- UCbase & miRfunc: a database of ultraconserved sequences and microRNA function
- Contrast agents and renal cell apoptosis
- miR221/222 in Cancer: Their Role in Tumor Progression and Response to Therapy
- Small non-coding RNA and cancer
- miR-130a targets MET and induces TRAIL-sensitivity in NSCLC by downregulating miR-221 and 222
- MiR-494 is regulated by ERK1/2 and modulates TRAIL-induced apoptosis in non–small-cell lung cancer through BIM down-regulation
- miR-221/222 overexpession in human glioblastoma increases invasiveness by targeting the protein phosphate PTPμ
- MiR-34a/c-Dependent PDGFR-α/β Downregulation Inhibits Tumorigenesis and Enhances TRAIL-Induced Apoptosis in Lung Cancer
- Effect of miR-21 and miR-30b/c on TRAIL-induced apoptosis in glioma cells
- miR-212 Increases Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Sensitivity in Non–Small Cell Lung Cancer by Targeting the Antiapoptotic Protein PED
- Cross-talk between MET and EGFR in non-small cell lung cancer involves miR-27a and Sprouty2
- Akt Regulates Drug-Induced Cell Death through Bcl-w Downregulation
- miR-34c may protect lung cancer cells from paclitaxel-induced apoptosis
- miR-221/222 Target the DNA Methyltransferase MGMT in Glioma Cells
- miR-579-3p controls melanoma progression and resistance to target therapy
- MiR-221 promotes stemness of breast cancer cells by targeting DNMT3b